SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027263
Filing Date
2023-06-09
Accepted
2023-06-09 16:09:15
Documents
13
Period of Report
2023-06-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20230609.htm   iXBRL 8-K 90422
2 EX-3.1 nktx-ex3_1.htm EX-3.1 18062
  Complete submission text file 0000950170-23-027263.txt   237441

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20230609.xsd EX-101.SCH 2452
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20230609_pre.xml EX-101.PRE 11854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20230609_lab.xml EX-101.LAB 14441
7 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20230609_htm.xml XML 5068
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 231005330
SIC: 2834 Pharmaceutical Preparations